SAN DIEGO--(BUSINESS WIRE)--Biocom, the association representing the life science industry of California, today announced the appointment of Taylor Crouch, Michael Farrington, Marc T. Morley and Peter Silvester to its board.
“With backgrounds in finance, intellectual property, marketing and leadership, our newest members join us with a broad range of experience, helping to diversify the expertise of our current board,” said Joe Panetta, president and CEO of Biocom. “As California continues to build its leadership position in scientific research, advancement and innovation, it is important to bring fresh voices to the organizations fostering the growth of the industry. These new board appointments will help to bolster our support for our member companies throughout the state.”
The four members join Biocom’s board with a wide range of skills and knowledge:
- Taylor Crouch serves as president and CEO of Organovo, a biotech company pioneering the 3D bio-printing of tissue which emulates human function. He brings 30 years of experience building and leading life science companies.
- Michael Farrington is vice president of global marketing at NuVasive, where he is responsible for leading the company’s marketing strategy, including launch, commercialization, customer experience, digital and brand strategy.
- Marc T. Morley, member at Mintz Levin, who works with clients to develop and implement effective intellectual property strategies and is recognized as one of San Diego’s top life science IP attorneys.
- Peter Silvester, senior vice president and president of life sciences solutions for Thermo Fisher Scientific, provides executive oversight of Thermo Fisher’s biosciences, genetic sciences and clinical next-generation sequencing businesses as well as life sciences finance, legal, HR, licensing and commercial supply functions.
View Biocom’s full Board of Directors here.
Biocom is the largest, most experienced leader and advocate for California’s life science sector. We work on behalf of more than 1,000 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to its San Diego headquarters, Biocom operates a core office serving the Los Angeles market, satellite offices in Washington, D.C. and Tokyo, and has a continuous staff presence in the San Francisco Bay Area and Sacramento. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.